Laboratory Of America Holdings Stock News

This article was originally published on TipRanks.com Global life sciences company Laboratory Corporation of America Holdings (NYSE: LH), popularly known as Labcorp, entered into a The post Labcorp to Acquire Personal Genome Diagnostics for $575M appeared first on Smarter Analyst .

Sierra Capital LLC decreased its position in shares of Laboratory Co. of America Holdings (NYSE:LH) by 50.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 389 shares of the medical research companys stock after selling 398 shares []

Laboratory Corp of America Holdings (NYSE: LH ) has agreed to acquire Personal Genome Diagnostics Inc (PGDx), a cancer genomics firm with a portfolio of comprehensive liquid biopsy and tissue-based products. Labcorp will pay $450 million in cash at closing and up to an additional $125 million on achieving future performance milestones. The addition of PGDx complements & accelerates Labcorps existing liquid biopsy capabilities Full story available on Benzinga.com

Redhawk Wealth Advisors Inc. bought a new position in Laboratory Co. of America Holdings (NYSE:LH) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,122 shares of the medical research companys stock, valued at approximately $316,000. Other institutional investors and hedge funds have also recently []

Nordea Investment Management AB reduced its position in shares of Laboratory Co. of America Holdings (NYSE:LH) by 82.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 220,334 shares of the medical research company’s stock after selling 1,012,130 shares during the […] The post Laboratory Co. of America Holdings (NYSE:LH) Shares Sold by Nordea Investment Management AB appeared first on ETF Daily News .

Laboratory Corp of America Holdings (NYSE: LH) has agreed to acquire Personal Genome Diagnostics Inc (PGDx), a cancer genomics firm with a portfolio of comprehensive liquid biopsy and tissue-based

Investors are optimistic about LabCorp's (LH) strong third-quarter 2021 results and raised guidance.

Our indicative theme on Covid-19 Testing Stocks – which includes companies that produce or carry out tests for Covid-19 infections - is up by 24% year-to-date, roughly in line with the S&P 500. Whil

Laboratory Co. of America (NYSE:LH) had its price objective raised by Morgan Stanley from $377.00 to $380.00 in a research note issued to investors on Friday morning, Price Targets.com reports. They currently have an overweight rating on the medical research companys stock. Other equities analysts have also issued reports about the stock. Zacks Investment Research []

Wall Street analysts forecast that Laboratory Co. of America Holdings (NYSE:LH) will post sales of $3.83 billion for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Laboratory Co. of Americas earnings. The highest sales estimate is $3.87 billion and the lowest is $3.74 billion. Laboratory Co. of America posted sales []

Janney Montgomery Scott LLC grew its holdings in Laboratory Co. of America Holdings (NYSE:LH) by 30.4% during the third quarter, Holdings Channel.com reports. The firm owned 24,165 shares of the medical research companys stock after acquiring an additional 5,634 shares during the quarter. Janney Montgomery Scott LLCs holdings in Laboratory Co. of America were worth []

Busey Wealth Management increased its holdings in Laboratory Co. of America Holdings (NYSE:LH) by 2.1% during the 3rd quarter, HoldingsChannel reports. The fund owned 50,670 shares of the medical research companys stock after acquiring an additional 1,019 shares during the quarter. Busey Wealth Managements holdings in Laboratory Co. of America were worth $14,260,000 as of []

Laboratory Co. of America Holdings (NYSE:LH) shares hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $311.78 and last traded at $311.50, with a volume of 6597 shares changing hands. The stock had previously closed at $307.16. Several analysts recently issued reports on the stock. Morgan Stanley []

State of Michigan Retirement System reduced its position in Laboratory Co. of America Holdings (NYSE:LH) by 83.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 24,247 shares of the medical research company’s stock after selling 122,600 shares during the quarter. State of Michigan Retirement […]

Laboratory Co. of America (NYSE:LH) had its price objective increased by Wells Fargo & Company from $330.00 to $340.00 in a report released on Tuesday, The Fly reports. The brokerage presently has an overweight rating on the medical research companys stock. Wells Fargo & Companys target price points to a potential upside of 10.69% from []